Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 1-Cyanoallyl Acetate SCHEMBL347682 | 0.78 | — | — | |
| SCHEMBL11044129 | 0.77 | — | — | |
| SCHEMBL1960557 | 0.75 | — | — | |
| SCHEMBL371301 | 0.74 | ALDH1A1 (0.38) | ALDH1A1TSHR | |
| 1-Cyanoallyl Acetate SCHEMBL28614624 | 0.74 | TSHR (0.34) | TSHR | |
| SCHEMBL8744242 | 0.74 | ALDH1A1 (0.30) | ALDH1A1TSHRMEN1CYP2C19RECQL | |
| SCHEMBL1963001 | 0.74 | — | — | |
| SCHEMBL11637243 | 0.74 | TSHR (0.35) | ALDH1A1TSHR | |
| SCHEMBL196173 | 0.74 | TSHR (0.35) | ALDH1A1TSHR | |
| SCHEMBL28864277 | 0.73 | CES1 (0.32) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2542531-B1 | PROCESS FOR SYNTHESIS OF FIPRONIL | GHARDA KEKI HORMUSJI (IN) | 2014-09-17 | — | — | EP | claimed |
| US-8507693-B2 | Process for synthesis of fipronil | Gharda Medical and Advanced Technologies Foundation (IN) | 2013-08-13 | — | — | US | claimed |
| US-20130030190-A1 | PROCESS FOR SYNTHESIS FIPRONIL | Gharda Medical and Advanced Technologies Foundation (IN) | 2013-01-31 | — | — | US | claimed |
| EP-2542531-A1 | PROCESS FOR SYNTHESIS OF FIPRONIL | Gharda, Keki Hormusji (IN) | 2013-01-09 | — | — | EP | claimed |
| WO-2011107998-A1 | PROCESS FOR SYNTHESIS OF FIPRONIL | GHARDA KEKI HORMUSJI (IN) | 2011-09-09 | — | — | WO | claimed |
| EP-2542531-B1 | PROCESS FOR SYNTHESIS OF FIPRONIL | GHARDA KEKI HORMUSJI (IN) | 2014-09-17 | — | — | EP | disclosed |
| US-8507693-B2 | Process for synthesis of fipronil | Gharda Medical and Advanced Technologies Foundation (IN) | 2013-08-13 | — | — | US | disclosed |
| US-20130030190-A1 | PROCESS FOR SYNTHESIS FIPRONIL | Gharda Medical and Advanced Technologies Foundation (IN) | 2013-01-31 | — | — | US | disclosed |
| EP-2542531-A1 | PROCESS FOR SYNTHESIS OF FIPRONIL | Gharda, Keki Hormusji (IN) | 2013-01-09 | — | — | EP | disclosed |
| WO-2011107998-A1 | PROCESS FOR SYNTHESIS OF FIPRONIL | GHARDA KEKI HORMUSJI (IN) | 2011-09-09 | — | — | WO | disclosed |
| EP-0867427-B1 | Process for producing branched aldehydes | KURARAY CO (JP) | 2002-11-06 | — | — | EP | disclosed |
| US-5932761-A | Process for producing branched aldehydes | KURARAY CO., LTD. (JP) | 1999-08-03 | — | — | US | disclosed |
| EP-0867427-A1 | Process for producing branched aldehydes | KURARAY CO., LTD. (JP) | 1998-09-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130030190-A1 | PROCESS FOR SYNTHESIS FIPRONIL | FIP1L1, CYP2F1, PFAS | ALDH1A1 918/4885TSHR 539/4885MEN1 2825/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.